Inovio Pharmaceuticals CEO J Kim's 2012 pay rises 7% to $966K
Inovio Pharmaceuticals reports 2012 executive compensation
By ExecPay News
Published: March 29, 2013
Inovio Pharmaceuticals reported fiscal year 2012 executive compensation information on March 29, 2013.
In 2012, five executives at Inovio Pharmaceuticals received on average a compensation package of $568K, a 1% increase compared to previous year.
Average pay of disclosed executives at Inovio Pharmaceuticals
J. Joseph Kim, Chief Executive Officer, received $966K in total, which increased by 7% compared to 2011. 57% of Kim's compensation, or $546K, was in salary. Kim also received $211K in bonus, $201K in option awards, as well as $7.8K in other compensation.
Niranjan Y. Sardesai, Chief Operating Officer, received a compensation package of $475K, which increased by 3% compared to previous year. 62% of the compensation package, or $294K, was in salary.
Niranjan Y. Sardesei, Chief Operating Officer, earned $475K in 2012, a 3% increase compared to previous year.
Peter D. Kies, Chief Financial Officer, received $461K in 2012, which increases by 2% compared to 2011.
Mark L. Bagarazzi, Chief Medical Officer, earned $460K in 2012, a 3% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 29, 2013.